About Rapid Micro Biosystems
Rapid Micro Biosystems is a company based in Bedford (United Kingdom) founded in 2006. Rapid Micro Biosystems has raised $349.7 million across 15 funding rounds from investors including Kleiner Perkins, Comerica and BlackRock. The company has 163 employees as of December 31, 2024. Rapid Micro Biosystems offers products and services including Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables. Rapid Micro Biosystems operates in a competitive market with competitors including BacterOMIC and Rapiddx Technologies, among others.
- Headquarter Bedford, United Kingdom
- Employees 163 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rapid Micro Biosystems, Inc.
-
Annual Revenue
$28.05 M (USD)24.57as on Dec 31, 2024
-
Net Profit
-$46.89 M (USD)10.63as on Dec 31, 2024
-
EBITDA
-$46.56 M (USD)12.91as on Dec 31, 2024
-
Total Equity Funding
$349.7 M (USD)
in 15 rounds
-
Latest Funding Round
$81 M (USD), Series E
Mar 16, 2021
-
Investors
Kleiner Perkins
& 21 more
-
Employee Count
163
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Rapid Micro Biosystems
Rapid Micro Biosystems is a publicly listed company on the NASDAQ with ticker symbol RPID in USA, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Rapid Micro Biosystems
Rapid Micro Biosystems offers a comprehensive portfolio of products and services, including Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables.
Automated platform for rapid microbial quality control testing
Technology for quick detection of contaminants in samples
Software for managing and analyzing microbial test data
Items used in automated microbial testing processes
People of Rapid Micro Biosystems
Unlock access to complete
Funding Insights of Rapid Micro Biosystems
Rapid Micro Biosystems has successfully raised a total of $349.7M across 15 strategic funding rounds. The most recent funding activity was a Series E round of $81 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Series E — $81.0M
-
First Round
First Round
(01 Jun 2006)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series E - Rapid Micro Biosystems | Valuation | BlackRock , Xeraya Capital |
|
| May, 2020 | Amount | Debt – Conventional - Rapid Micro Biosystems | Valuation |
investors |
|
| May, 2020 | Amount | Series E - Rapid Micro Biosystems | Valuation | Endeavour Vision , Ally Bridge Group |
Investors in Rapid Micro Biosystems
Rapid Micro Biosystems has secured backing from 22 investors, including institutional and venture fund investors. Prominent investors backing the company include Kleiner Perkins, Comerica and BlackRock.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rapid Micro Biosystems
Financial Statements - Rapid Micro Biosystems
Rapid Micro Biosystems Comparisons
Competitors of Rapid Micro Biosystems
Rapid Micro Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BacterOMIC and Rapiddx Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a system for antibiotic susceptibility testing
|
|
| domain | founded_year | HQ Location |
Antimicrobial susceptibility platform is developed via microfluidics and sensor technology.
|
Latest news on Rapid Micro Biosystems
Frequently Asked Questions about Rapid Micro Biosystems
Rapid Micro Biosystems was founded in 2006.
Rapid Micro Biosystems is headquartered in Bedford, United Kingdom. It is registered at Bedford, Bedfordshire, United Kingdom.
Rapid Micro Biosystems is a funded company, having raised a total of $349.7M across 15 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Rapid Micro Biosystems is 163.
Annual revenue of Rapid Micro Biosystems is $28.05M as on Dec 31, 2024.
Founded in 2006, Rapid Micro Biosystems operates in the biotechnology sector, focusing on microbial detection solutions. The Growth Direct system is provided, featuring automated imaging for early microcolony counting via autofluorescence measurement. Services such as on-site installation, instrument validation, and regulatory compliance support are offered. Applications include environmental monitoring, sterility testing, and bioburden analysis, with operations based in Bedford, United Kingdom.
Rapid Micro Biosystems's top competitors include BacterOMIC and Rapiddx Technologies.
Rapid Micro Biosystems offers Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables.
Yes, Rapid Micro Biosystems is publicly traded on NASDAQ under the ticker symbol RPID.
Rapid Micro Biosystems has 22 investors. Key investors include Kleiner Perkins, Comerica, BlackRock, TPG, and T. Rowe Price.
The ticker symbol of Rapid Micro Biosystems is RPID on NASDAQ.